Our professionals

Imagen del Dr. Juan Pablo de Torres. Especialista en Neumología de la Clínica Universidad de Navarra. El Dr. Pablo de Torres se dedica preferencialmente al estudio y tratamiento de la Enfermedad Pulmonar Obstructiva Crónica, el enfisema y su relación con el cáncer de pulmón.

Dr. Juan Pablo de Torres

Co-Director of the Department of Pulmonology.
Specialist in Pulmonology.
Assessment and treatment of chronic obstructive pulmonary disease, emphysema, and their relationship with lung cancer.

Works at: Navarre headquarters
Be part of: Clínica Universidad de Navarra Cancer Center Clínica Universidad de Navarra
INDEX H 54

Professional career

Medical degree from the University of the Republic (Montevideo, Uruguay).

PhD in Medicine from the University of Navarra, Pamplona.

Internal Medicine residency at Jackson Memorial Hospital, University of Miami, Miami, FL, USA.

Fellowship in Pulmonology and Critical Care at Tufts University, Boston, MA, USA.

Board certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine by the ABIM (USA).

He has worked since 2006 as a Pulmonology Consultant at Clínica Universidad de Navarra.

From 2019 to 2022, he worked as a pulmonologist at Kingston General Hospital (Kingston, Ontario, Canada) and during that period was also a Professor of Medicine at Queen’s University (Kingston, Ontario, Canada).

RESEARCH AREAS

  • He is a member of the scientific committee and principal investigator of the international BODE research group, internationally recognized for more than 100 publications in COPD research.
  • He is a member of the scientific committee and principal investigator of the CHAIN study for longitudinal follow-up of patients with COPD.
  • He has participated as principal investigator in the recent EPISCAN II study on the prevalence of COPD in Spain.
  • He is or has been a member of the editorial board of the journals PLOS ONE and Archivos de Bronconeumología.
  • He has received funding for more than 15 research studies on COPD, emphysema, and their association with lung cancer from public and private entities.
  • He has recently received funding (€600,000) from ISCIII and SEPAR to explore anti-aging effects in patients with COPD/emphysema.

AREAS OF INTEREST

  • COPD, emphysema, and their relationship with lung cancer and cardiovascular disease.
  • Determination of the prevalence and impact of comorbidities associated with COPD using chest CT.
  • Determination of body composition using low-dose CT in patients with COPD and its relationship with the natural history of the disease.
  • Impact of metformin as an anti-aging agent in patients with COPD/emphysema

Activity

In teaching

  • He has been a Professor of Medicine at the University of Navarra and accredited by ANECA since 2009.
  • He was a Professor of Medicine at Queen’s University (Kingston, Ontario, Canada).
  • He has supervised 8 PhD theses.

In research

  • He has authored more than 150 PubMed-indexed articles, one-third of them in Q1 journals.
  • He has presented more than 250 communications at national and international conferences.
  • He has delivered more than 30 lectures at national and international conferences. 
More information

Icono Scopus   SCOPUS

Icono ORCID   ORCID

Icono RESEARCHID   RESEARCHID